About Tivity Health (NASDAQ:TVTY)
Tivity Health, Inc. provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.
Industry, Sector and Symbol
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
Trailing P/E Ratio23.84
Forward P/E Ratio18.50
Sales & Book Value
Annual Sales$556.94 million
Price / Sales2.86
Cash Flow$2.1571 per share
Price / Cash18.52
Book Value$6.86 per share
Price / Book5.82
EPS (Most Recent Fiscal Year)$1.68
Net Income$63.71 million
Return on Equity29.17%
Return on Assets11.27%
Tivity Health (NASDAQ:TVTY) Frequently Asked Questions
What is Tivity Health's stock symbol?
Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."
How were Tivity Health's earnings last quarter?
Tivity Health (NASDAQ:TVTY) announced its earnings results on Thursday, February, 22nd. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.32 by $0.09. The company earned $139.40 million during the quarter, compared to the consensus estimate of $138.22 million. Tivity Health had a return on equity of 29.17% and a net margin of 11.44%. The company's revenue was up 11.6% on a year-over-year basis. During the same period last year, the firm earned $0.35 earnings per share. View Tivity Health's Earnings History.
When is Tivity Health's next earnings date?
What guidance has Tivity Health issued on next quarter's earnings?
Tivity Health updated its FY18 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of $2.12-2.20 for the period, compared to the Thomson Reuters consensus estimate of $1.70. The company issued revenue guidance of $607-625 million, compared to the consensus revenue estimate of $616.41 million.
What price target have analysts set for TVTY?
7 equities research analysts have issued 12-month price targets for Tivity Health's shares. Their predictions range from $41.00 to $53.00. On average, they anticipate Tivity Health's stock price to reach $47.1429 in the next year. View Analyst Ratings for Tivity Health.
Who are some of Tivity Health's key competitors?
Some companies that are related to Tivity Health include UDG Healthcare (UDHCF), Spark Therapeutics (ONCE), Inogen (INGN), Indivior (INDV), Array BioPharma (ARRY), arGEN-X BV (ARGX), China Biologic Products (CBPO), Tesaro (TSRO), Immunomedics (IMMU), Magellan Health (MGLN), NuVasive (NUVA), Halozyme Therapeutics (HALO), Nevro (NVRO), Ultragenyx Pharmaceutical (RARE), Emergent BioSolutions (EBS), Foundation Medicine (FMI), Amicus Therapeutics (FOLD) and Ascendis Pharma (ASND).
Who are Tivity Health's key executives?
Tivity Health's management team includes the folowing people:
- Mr. Donato J. Tramuto, CEO & Director (Age 61)
- Mr. Glenn Hargreaves, Chief Accounting Officer & Controller (Age 51)
- Ms. Mary S. Flipse, Chief Legal Officer (Age 51)
- Mr. Adam C. Holland, Chief Financial Officer (Age 39)
- Mr. Paul Edmisten, Chief Information Officer
Has Tivity Health been receiving favorable news coverage?
Media coverage about TVTY stock has been trending somewhat positive this week, Accern reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tivity Health earned a news impact score of 0.03 on Accern's scale. They also gave headlines about the company an impact score of 45.70 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.
How do I buy shares of Tivity Health?
Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tivity Health's stock price today?
One share of TVTY stock can currently be purchased for approximately $39.95.
How big of a company is Tivity Health?
Tivity Health has a market capitalization of $1.60 billion and generates $556.94 million in revenue each year. The company earns $63.71 million in net income (profit) each year or $1.68 on an earnings per share basis. Tivity Health employs 475 workers across the globe.
How can I contact Tivity Health?
Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 615-614-4929 or via email at [email protected]
MarketBeat Community Rating for Tivity Health (TVTY)MarketBeat's community ratings are surveys of what our community members think about Tivity Health and other stocks. Vote "Outperform" if you believe TVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tivity Health (NASDAQ:TVTY) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Tivity Health (NASDAQ TVTY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.73%
Tivity Health (NASDAQ TVTY) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|4/2/2018||Donato Tramuto||CEO||Sell||20,000||$39.30||$786,000.00|| |
|3/1/2018||Donato Tramuto||CEO||Sell||20,000||$38.53||$770,600.00||189,596|| |
|11/21/2017||Conan Laughlin||Director||Sell||140,000||$34.90||$4,886,000.00|| |
|11/17/2017||Conan Laughlin||Director||Sell||490,000||$34.34||$16,826,600.00|| |
|11/15/2017||Conan Laughlin||Director||Sell||115,087||$33.87||$3,897,996.69|| |
|11/6/2017||Conan Laughlin||Director||Sell||120,000||$47.52||$5,702,400.00|| |
|11/3/2017||Mary Flipse||Insider||Sell||5,000||$48.11||$240,550.00||45,167|| |
|11/2/2017||Glenn Hargreaves||CAO||Sell||5,805||$45.15||$262,095.75||44,448|| |
|9/26/2017||Glenn Hargreaves||Insider||Sell||7,137||$40.00||$285,480.00||52,180|| |
|9/25/2017||Mary Flipse||Insider||Sell||7,808||$39.00||$304,512.00||57,975|| |
|8/21/2017||Glenn Hargreaves||Insider||Sell||23,448||$37.78||$885,865.44||62,211|| |
|8/18/2017||Mary Flipse||Insider||Sell||14,020||$37.03||$519,160.60||61,167|| |
|8/11/2017||Mary Flipse||Insider||Sell||1,340||$37.32||$50,008.80||75,187|| |
|8/4/2017||Glenn Hargreaves||Insider||Sell||21,105||$38.00||$801,990.00||59,077|| |
|8/1/2017||Conan Laughlin||Director||Sell||1,750,000||$37.90||$66,325,000.00|| |
|5/3/2017||Mary Jane England||Director||Sell||1,763||$31.95||$56,327.85||19,453|| |
|4/3/2017||Mary Jane England||Director||Sell||2,674||$29.05||$77,679.70||21,216|| |
|3/3/2017||Mary Jane England||Director||Sell||2,340||$28.60||$66,924.00||23,890|| |
|3/1/2017||Conan Laughlin||Insider||Sell||2,000,000||$28.30||$56,600,000.00|| |
|2/3/2017||Mary Jane England||Director||Sell||2,343||$25.55||$59,863.65||26,230|| |
|1/3/2017||Mary Jane England||Director||Sell||2,298||$22.40||$51,475.20||28,573|| |
|11/18/2016||Mary Jane England||Director||Sell||3,600||$22.26||$80,136.00||30,871|| |
|11/4/2016||Donato Tramuto||CEO||Buy||5,060||$19.95||$100,947.00||275,442|| |
|11/4/2016||Robert J Greczyn Jr||Director||Buy||5,000||$19.55||$97,750.00||30,578|| |
|8/26/2016||Mary Jane England||Director||Sell||3,816||$24.78||$94,560.48||39,068|| |
|11/13/2015||Conan Laughlin||Director||Buy||47,600||$12.65||$602,140.00||6,203|| |
|11/12/2015||Conan Laughlin||Director||Buy||252,400||$12.49||$3,152,476.00||6,203|| |
|11/5/2015||Conan Laughlin||Director||Buy||350,000||$11.51||$4,028,500.00||6,203|| |
|11/3/2015||Donato Tramuto||CEO||Buy||8,740||$11.47||$100,247.80||304,186|| |
|11/3/2015||Lee Shapiro||Director||Buy||4,359||$11.42||$49,779.78||10,562|| |
|7/31/2014||North Tide Capital, Llc||Major Shareholder||Sell||100,000||$17.29||$1,729,000.00|| |
|12/18/2013||North Tide Capital, Llc||major shareholder||Buy||140,000||$14.11||$1,975,400.00|| |
|11/7/2013||Donato Tramuto||Director||Buy||4,200||$11.77||$49,434.00||4,200|| |
|10/29/2013||Alfred Lumsdaine||CFO||Buy||5,000||$10.80||$54,000.00|| |
|8/14/2013||Alfred Lumsdaine||CFO||Sell||9,425||$18.64||$175,682.00||17,821|| |
|8/14/2013||Ben Leedle, Jr.||CEO||Sell||293,984||$18.68||$5,491,621.12||201,814|| |
|6/3/2013||Jay C Bisgard||Director||Sell||4,869||$14.58||$70,990.02|| |
|5/17/2013||Jay C Bisgard||Director||Sell||2,039||$14.50||$29,565.50|| |
|5/14/2013||Jay C Bisgard||Director||Sell||18,343||$14.51||$266,156.93|| |
|5/9/2013||John W Ballantine||Director||Sell||27,400||$14.02||$384,148.00|| |
Tivity Health (NASDAQ TVTY) News Headlines
Tivity Health (NASDAQ:TVTY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tivity Health (NASDAQ:TVTY) Income Statement, Balance Sheet and Cash Flow Statement
Tivity Health (NASDAQ TVTY) Stock Chart for Monday, April, 23, 2018